Found 183 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is P  [Clear All Filters]
Journal Article
M. Keefer, Gilmour, J., Hayes, P., Gill, D., Kopycinski, J., Cheeseman, H., Cashin-Cox, M., Naarding, M., Clark, L., Fernandez, N., Bunce, C., Hay, C., Welsh, S., ,, Loughran, K., Barin, B., Cormier, E., Cox, J. H., Fast, P., and Excler, J., A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults, PLoS One, vol. 7, p. e41936, 2012.
G. Omosa-Manyonyi, Mpendo, J., Ruzagira, E., Kilembe, W., Chomba, E., Roman, F., Bourguignon, P., Koutsoukos, M., Collard, A., Voss, G., Laufer, D., Stevens, G., Hayes, P., Clark, L., Cormier, E., Dally, L., Barin, B., ,, Gilmour, J., Cox, J., Fast, P., and Priddy, F., A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults, PLoS One, vol. 10, p. e0125954, 2015.
M. E. Enama, Ledgerwood, J. E., Novik, L., Nason, M. C., Gordon, I. J., Holman, L., Bailer, R. T., Roederer, M., Koup, R. A., ,, Nabel, G. J., and Graham, B. S., Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (i.m.), Subcutaneous (s.c.) and Intradermal (i.d.) Administration (VRC 011), PLoS ONE, vol. 9, p. e91366, 2014.
T. C. Heineman, Schleiss, M., Bernstein, D. I., Spaete, R. R., Yan, L., Duke, G., Prichard, M., Wanh, Z., Yan, Q., Sharp, M. A., Klein, N., Arvin, A. M., and Kemble, G., A Phase I Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimeric Vaccines, J Infec Dis, vol. 193, pp. 1350-1360, 2006.
R. W. Frenck, Baqar, S., Alexander, W., Dickey, M., McNeal, M., El-Khorazaty, J., Baughman, H., Hoeper, A., Barnoy, S., Suvarnapunya, A. E., Kaminski, R. W., and Venkatesan, M. M., A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei., Vaccine, vol. 36, no. 32 Pt B, pp. 4880-4889, 2018.
H. X. Chen, Mooney, M., Boron, M., Vena, D., Mosby, K., Grochow, L., Jaffe, C., Rubinstein, L., Zwiebel, J., and Kaplan, R. S., Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients with Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301, J Clin Oncol, vol. 24, pp. 3354-3360, 2006.
S. E. Frey, Winokur, P. L., Hill, H., Goll, J. B., Chaplin, P., and Belshe, R. B., Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID 50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-Naïve Individuals, Vaccine, vol. 32, pp. 2732-2739, 2014.
M. J. McElrath, Corey, L., Montefiori, D., Wolff, M., Schwartz, D., Keefer, M., Belshe, R., Graham, B. S., Matthews, T., Wright, P., Gorse, G., Dolin, R., Berman, P., Francis, D., Duliege, A. M., Bolognesi, D., Stablein, D., Ketter, N., and Fast, P., A Phase II Study of Two HIV-1 Envelope Vaccines Comparing their Immunogenicity in Populations at Risk for Acquiring HIV-1 Infection, AIDS Res HumRetroviruses, vol. 16, pp. 907-19, 2000.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, Vaccine, vol. 33, pp. 163-173, 2015.
K. Csaky, Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics, 2004.
K. Ballen, Mendizabal, A. M., Cutler, C., Politikos, I., Jamieson, K., Shpall, E. J., Dey, B. R., Attar, E., McAfee, S., Delaney, C., McCarthy, P., Ball, E. D., Kamble, R., Avigan, D., Maziarz, R. T., Ho, V. T., Koreth, J., Alyea, E., Soiffer, R., ,, Boussiotis, V., Spitzer, T. R., and Antin, J. H., Phase II Trial of Parathyroid Hormone After Double Umbilical Cord Blood Transplantation, Biol Blood Marrow Transplant, vol. 18, no. 12, pp. 1851-1858, 2012.
E. Hook, Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Seña, A., Martin, D., Langley, C., McNeil, L., and Wolff, M., A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for Treatment of Early Syphilis, J Infect Dis, vol. 201, pp. 1729-1735, 2010.
J. M. Vose, Carter, S., Burns, L. J., Ayala, E., Press, O. W., Moskowitz, C. H., Stadtmauer, E. A., Mineshi, S., Ambinder, R., Fenske, T., Horowitz, M., Fisher, R., and Tomblyn, M., Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT C, J Clin Oncol, vol. 31, pp. 1662-1668, 2013.
M. Horwitz, Wease, S., Blackwell, B., Valcarcel, D., Frassoni, F., Boelens, J. J., Nierkens, S., Jagasia, M., Wagner, J. E., Kuball, J., Koh, L. P., Majhail, N. S., Stiff, P., Hanna, R., Hwang, W. Y. K., Kurtzberg, J., Cilloni, D., Freedman, L. S., Montesinos, P., and Sanz, G., Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide., J Clin Oncol, 2018.
P. A. Carpenter, Logan, B. R., Lee, S. J., Weisdorf, D. J., Johnston, L., Costa, L. J., Kitko, C. L., Bolaños-Meade, J., Sarantopoulos, S., Alousi, A. M., Abhyankar, S., Waller, E. K., Mendizabal, A., Zhu, J., O'Brien, K. A., Lazaryan, A., Wu, J., Nemecek, E. R., Pavletic, S. Z., Cutler, C. S., Horowitz, M. M., and Arora, M., A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801., Haematologica, vol. 103, no. 11, pp. 1915-1924, 2018.
I. U. Ansari, Allen, T., Berical, A., Stock, P. G., Barin, B., and Striker, R., Phenotypic Analysis of NS5A Variant from Liver Transplant Patient with Increased Cyclosporine Susceptibility, Virology, vol. 436, pp. 268-273, 2013.
M. Chehade, Jones, S. M., Pesek, R. D., A Burks, W., Vickery, B. P., Wood, R. A., Leung, D. Y. M., Furuta, G. T., Fleischer, D. M., Henning, A. K., Dawson, P., Lindblad, R. W., Sicherer, S. H., J Abonia, P., Sherrill, J. D., Sampson, H. A., and Rothenberg, M. E., Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research., J Allergy Clin Immunol Pract, vol. 6, no. 5, pp. 1534-1544.e5, 2018.
V. P. Thompson, Schenkel, A. B., Penugonda, B., Wolff, M. S., Zeller, G. G., Wu, H., Vena, D., Grill, A. C., and Curro, F. A., A Pilot Study of Dentists' Assessment of Caries Detection and Staging Systems Applied to Early Caries: PEARL Network Findings, Gen Dent, vol. 64, no. 3, pp. 20-27, 2016.
M. D. Abràmoff, Lavin, P. T., Birch, M., Shah, N., and Folk, J. C., Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices., npj Digital Medicine, vol. 1, no. 1, p. 39, 2018.
R. S. Daum, Miller, L. G., Immergluck, L., Fritz, S., C Creech, B., Young, D., Kumar, N., Downing, M., Pettibone, S., Hoagland, R., Eells, S. J., Boyle, M. G., Parker, T. Chan, and Chambers, H. F., A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses, N Engl J Med, vol. 376, no. 26, pp. 2545-2555, 2017.
T. Clemons, Lindblad, A., Moos, M., and Odenkirchen, J., A plan for community physician involvement in clinical studies, 2006.
A. M Zaid, Wu, J., Wu, C., Logan, B. R., Yu, J., Cutler, C., Antin, J. H., Paczesny, S., and Choi, S. W., Plasma Biomarkers of Risk for Death in a Multicenter Phase 3 trial with Uniform Transplant Characteristics Post-Allogeneic HCT, Blood, vol. 129, no. 12, pp. 162-170, 2017.
M. J. Egorin, Rosen, D. M., Sridhara, R., Sensenbrenner, L., and Cottler-Fox, M., Plasma concentrations and pharmacokinetics of dimethylsulfoxide and metabolites in patients undergoing peripheral stem-cell transplants, J Clin Oncology, vol. 16, pp. 610-15, 1998.
S. C. Johnston, Easton, J. D., Farrant, M., Barsan, W., Battenhouse, H., Conwit, R., Dillon, C., Elm, J., Lindblad, A., Morgenstern, L., Poisson, S. N., and Palesch, Y., Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and Design, Int J Stroke, vol. 8, pp. 479-483, 2013.
D. F. Hoft, Xia, M., Zhang, G. L., Blazevic, A., Tennant, J., Kaplan, C., Matuschak, G., Dube, T. J., Hill, H., Schlesinger, L. S., Andersen, P. L., and Brusic, V., PO and ID BCG Vaccination in Humans Induce Distinct Mucosal and Systemic Immune Responses and CD4(+) T Cell Transcriptomal Molecular Signatures, Mucosal Immunol, vol. 11, no. 2, pp. 486-495, 2018.